Last reviewed · How we verify
surfactant and air (placebo)
This is a placebo control consisting of surfactant and air used in clinical trials to establish baseline comparisons for respiratory interventions.
This is a placebo control consisting of surfactant and air used in clinical trials to establish baseline comparisons for respiratory interventions. Used for Placebo control in respiratory disease trials.
At a glance
| Generic name | surfactant and air (placebo) |
|---|---|
| Also known as | survanta |
| Sponsor | China Medical University, China |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | FDA-approved |
Mechanism of action
Surfactant and air placebo mimics the physical administration of a respiratory treatment without delivering an active pharmaceutical agent. It serves as a control arm in clinical studies to differentiate true drug effects from placebo effects and natural disease progression in respiratory conditions.
Approved indications
- Placebo control in respiratory disease trials
Common side effects
Key clinical trials
- Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia (PHASE4)
- Efficacy and Safety of Curosurf® in Patients Invasively Ventilated for Severe Bronchiolitis Under 12 Months of Age (PHASE3)
- Prevention of Chronic Lung Disease (CLD) in Preterm Infants (PHASE4)
- SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants. (PHASE2)
- Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- surfactant and air (placebo) CI brief — competitive landscape report
- surfactant and air (placebo) updates RSS · CI watch RSS
- China Medical University, China portfolio CI